Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ARDX |
---|---|---|
09:32 ET | 60256 | 5.975 |
09:34 ET | 123320 | 5.87 |
09:36 ET | 35406 | 5.87 |
09:38 ET | 34432 | 5.83 |
09:39 ET | 36466 | 5.88 |
09:41 ET | 30685 | 5.91 |
09:43 ET | 14411 | 5.905 |
09:45 ET | 15322 | 5.93 |
09:48 ET | 20807 | 5.9 |
09:50 ET | 11888 | 5.88 |
09:52 ET | 2900 | 5.875 |
09:54 ET | 8972 | 5.8699 |
09:56 ET | 14646 | 5.895 |
09:57 ET | 30176 | 5.89 |
09:59 ET | 22128 | 5.88 |
10:01 ET | 19412 | 5.8797 |
10:03 ET | 29491 | 5.855 |
10:06 ET | 11746 | 5.85 |
10:08 ET | 11081 | 5.86 |
10:10 ET | 2275 | 5.885 |
10:12 ET | 36184 | 5.875 |
10:14 ET | 64977 | 5.85 |
10:15 ET | 7771 | 5.86 |
10:17 ET | 12263 | 5.855 |
10:19 ET | 57356 | 5.905 |
10:21 ET | 9030 | 5.92 |
10:24 ET | 18248 | 5.93 |
10:26 ET | 8040 | 5.91 |
10:28 ET | 11986 | 5.905 |
10:30 ET | 29868 | 5.9 |
10:32 ET | 27323 | 5.9 |
10:33 ET | 35934 | 5.9 |
10:35 ET | 21325 | 5.905 |
10:37 ET | 6341 | 5.9044 |
10:39 ET | 81699 | 5.9 |
10:42 ET | 10633 | 5.855 |
10:44 ET | 15725 | 5.86 |
10:46 ET | 2770 | 5.85 |
10:48 ET | 9096 | 5.8599 |
10:50 ET | 13666 | 5.86 |
10:51 ET | 3892 | 5.845 |
10:53 ET | 18290 | 5.815 |
10:55 ET | 14629 | 5.8451 |
10:57 ET | 6412 | 5.825 |
11:00 ET | 13991 | 5.8099 |
11:02 ET | 43098 | 5.8165 |
11:04 ET | 5910 | 5.805 |
11:06 ET | 17138 | 5.8099 |
11:08 ET | 3500 | 5.815 |
11:09 ET | 3418 | 5.83 |
11:11 ET | 5821 | 5.84 |
11:13 ET | 7375 | 5.825 |
11:15 ET | 14588 | 5.835 |
11:18 ET | 8250 | 5.835 |
11:20 ET | 4068 | 5.83 |
11:22 ET | 8688 | 5.835 |
11:24 ET | 12774 | 5.86 |
11:26 ET | 5063 | 5.86 |
11:27 ET | 6178 | 5.85 |
11:29 ET | 5602 | 5.88 |
11:31 ET | 5873 | 5.875 |
11:33 ET | 5749 | 5.88 |
11:36 ET | 11571 | 5.89 |
11:38 ET | 2503 | 5.905 |
11:40 ET | 3899 | 5.905 |
11:42 ET | 5040 | 5.905 |
11:44 ET | 20716 | 5.905 |
11:45 ET | 7700 | 5.895 |
11:47 ET | 6459 | 5.8999 |
11:49 ET | 16971 | 5.9 |
11:51 ET | 9340 | 5.885 |
11:54 ET | 8107 | 5.875 |
11:56 ET | 8894 | 5.865 |
11:58 ET | 1552 | 5.86 |
12:00 ET | 7933 | 5.865 |
12:02 ET | 14076 | 5.875 |
12:03 ET | 8933 | 5.87 |
12:05 ET | 7370 | 5.875 |
12:07 ET | 12439 | 5.885 |
12:09 ET | 3327 | 5.88 |
12:12 ET | 2306 | 5.875 |
12:14 ET | 4564 | 5.87 |
12:16 ET | 14895 | 5.87 |
12:18 ET | 3750 | 5.875 |
12:20 ET | 5804 | 5.875 |
12:21 ET | 4652 | 5.875 |
12:23 ET | 20938 | 5.885 |
12:25 ET | 11531 | 5.885 |
12:27 ET | 8485 | 5.87 |
12:30 ET | 4503 | 5.87 |
12:32 ET | 4159 | 5.8788 |
12:34 ET | 5507 | 5.885 |
12:36 ET | 2500 | 5.875 |
12:38 ET | 5654 | 5.88 |
12:39 ET | 7411 | 5.89 |
12:41 ET | 8375 | 5.88 |
12:43 ET | 10678 | 5.87 |
12:45 ET | 1200 | 5.86 |
12:48 ET | 4910 | 5.855 |
12:50 ET | 16478 | 5.83 |
12:52 ET | 10395 | 5.835 |
12:54 ET | 17631 | 5.845 |
12:56 ET | 7694 | 5.85 |
12:57 ET | 1555 | 5.85 |
12:59 ET | 2888 | 5.845 |
01:01 ET | 17530 | 5.84 |
01:03 ET | 8862 | 5.84 |
01:06 ET | 25452 | 5.805 |
01:08 ET | 4107 | 5.81 |
01:10 ET | 18802 | 5.815 |
01:12 ET | 6624 | 5.8299 |
01:14 ET | 8252 | 5.805 |
01:15 ET | 4828 | 5.82 |
01:17 ET | 6980 | 5.825 |
01:19 ET | 15022 | 5.84 |
01:21 ET | 6323 | 5.835 |
01:24 ET | 12003 | 5.85 |
01:26 ET | 10419 | 5.85 |
01:28 ET | 12710 | 5.865 |
01:30 ET | 30906 | 5.875 |
01:32 ET | 10194 | 5.85 |
01:33 ET | 6631 | 5.855 |
01:35 ET | 1900 | 5.855 |
01:37 ET | 20327 | 5.88 |
01:39 ET | 45813 | 5.865 |
01:42 ET | 5996 | 5.87 |
01:44 ET | 1628 | 5.865 |
01:46 ET | 3029 | 5.865 |
01:48 ET | 25883 | 5.86 |
01:50 ET | 18245 | 5.855 |
01:51 ET | 6431 | 5.855 |
01:53 ET | 11859 | 5.865 |
01:55 ET | 16203 | 5.865 |
01:57 ET | 1704 | 5.8699 |
02:00 ET | 5979 | 5.875 |
02:02 ET | 21484 | 5.875 |
02:04 ET | 3631 | 5.88 |
02:06 ET | 32957 | 5.9 |
02:08 ET | 29864 | 5.92 |
02:09 ET | 15793 | 5.92 |
02:11 ET | 23039 | 5.905 |
02:13 ET | 36132 | 5.88 |
02:15 ET | 27296 | 5.885 |
02:18 ET | 51535 | 5.8725 |
02:20 ET | 15798 | 5.865 |
02:22 ET | 7060 | 5.875 |
02:24 ET | 30480 | 5.855 |
02:26 ET | 1885 | 5.855 |
02:27 ET | 10935 | 5.865 |
02:29 ET | 19455 | 5.865 |
02:31 ET | 15034 | 5.88 |
02:33 ET | 17330 | 5.895 |
02:36 ET | 24458 | 5.895 |
02:38 ET | 21405 | 5.89 |
02:40 ET | 10190 | 5.8988 |
02:42 ET | 19581 | 5.9 |
02:44 ET | 21269 | 5.8999 |
02:45 ET | 6169 | 5.895 |
02:47 ET | 7162 | 5.895 |
02:49 ET | 16097 | 5.9 |
02:51 ET | 12759 | 5.925 |
02:54 ET | 5416 | 5.92 |
02:56 ET | 6335 | 5.92 |
02:58 ET | 18741 | 5.93 |
03:00 ET | 88671 | 5.91 |
03:02 ET | 38476 | 5.915 |
03:03 ET | 33494 | 5.885 |
03:05 ET | 13693 | 5.89 |
03:07 ET | 19180 | 5.9 |
03:09 ET | 84170 | 5.864 |
03:12 ET | 48445 | 5.9 |
03:14 ET | 41298 | 5.9099 |
03:16 ET | 58621 | 5.92 |
03:18 ET | 14021 | 5.905 |
03:20 ET | 116877 | 5.945 |
03:21 ET | 42252 | 5.925 |
03:23 ET | 29076 | 5.9 |
03:25 ET | 6314 | 5.895 |
03:27 ET | 7140 | 5.9 |
03:30 ET | 22372 | 5.8785 |
03:32 ET | 19336 | 5.8799 |
03:34 ET | 44925 | 5.88 |
03:36 ET | 38781 | 5.91 |
03:38 ET | 22518 | 5.9 |
03:39 ET | 15386 | 5.905 |
03:41 ET | 45950 | 5.895 |
03:43 ET | 135150 | 5.905 |
03:45 ET | 23077 | 5.905 |
03:48 ET | 19464 | 5.915 |
03:50 ET | 39831 | 5.929 |
03:52 ET | 38208 | 5.9299 |
03:54 ET | 44811 | 5.9 |
03:56 ET | 65984 | 5.925 |
03:57 ET | 98579 | 5.88 |
03:59 ET | 736512 | 5.87 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ardelyx Inc | 1.4B | -21.1x | --- |
Gyre Therapeutics Inc | 1.4B | -16.6x | --- |
Arcus Biosciences Inc | 1.5B | -4.9x | --- |
Travere Therapeutics Inc | 1.4B | -3.5x | --- |
Xencor Inc | 1.5B | -7.3x | --- |
Immatics NV | 1.3B | -10.0x | --- |
Ardelyx, Inc. is a biopharmaceutical company. The Company focuses on discovery, development, and commercialization of advanced medicines that meet significant unmet medical needs. It has two commercial products IBSRELA (tenapanor) and XPHOZAH. Its product pipeline includes RDX013 Program and RDX020 Program. Tenapanor is a small molecule therapy in development for the treatment of or the control of hyperphosphatemia or serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor has a mechanism of action and acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3). IBSRELA is developed for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). XPHOZAH is a medicine for the control of serum phosphorus in adult patients with CKD on dialysis. RDX013 Program is a small molecule potassium secretagogue program for the treatment of hyperkalemia. RDX020 Program is a small molecule for treating metabolic acidosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $210.0M |
Shares Outstanding | 235.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.91 |
EPS | $-0.28 |
Book Value | $0.72 |
P/E Ratio | -21.1x |
Price/Sales (TTM) | 6.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -28.05% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.